| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,170 |
2,661 |
$243K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
481 |
348 |
$41K |
| 90686 |
|
1,840 |
1,578 |
$34K |
| 92551 |
|
1,016 |
888 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
865 |
590 |
$8K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
66 |
66 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
58 |
53 |
$6K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
42 |
38 |
$5K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
260 |
233 |
$4K |
| 90656 |
|
174 |
166 |
$3K |
| 3008F |
|
1,073 |
965 |
$3K |
| 99174 |
|
552 |
531 |
$3K |
| 96127 |
|
202 |
195 |
$943.46 |
| 90651 |
|
38 |
38 |
$874.00 |
| 0071A |
|
16 |
16 |
$640.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
20 |
14 |
$542.76 |
| 99173 |
|
201 |
150 |
$340.60 |
| 90633 |
|
12 |
12 |
$276.84 |
| 90670 |
|
13 |
12 |
$276.56 |
| 91320 |
|
13 |
13 |
$253.00 |
| 94760 |
|
22 |
18 |
$10.40 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$0.12 |
| 91307 |
|
16 |
16 |
$0.00 |